Verastem Inc Price Target Raised By Cantor Fitzgerald
Verastem Inc price target was raised to $17 by Cantor Fitzgerald last week. The new $17 price target represents 330% upside from the previous close of $3.95. Cantor has a
Tag
Lung cancer
Sell Cancer Genetics For an Awesome 133% Win!
April 16, 2017: Sell Cancer Genetics for an incredible 133% win in 85 days and congratulations if you made money on the trade.
December 9, 2016: H.C. Wainwright/ Rodman & Renshaw
ARIAD Pharmaceuticals Sell For 86.7% Win!
January 9, 2017: Sell ARIAD Pharmaceuticals on the news that it will be acquired by Takeda for $24 per share. This was a monster 86.7% win for us. Congratulations if